Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Westlake Chemical Partners (WLKP) EBT (2016 - 2025)

Westlake Chemical Partners' EBT history spans 13 years, with the latest figure at $84.5 million for Q4 2025.

  • For Q4 2025, EBT fell 3.58% year-over-year to $84.5 million; the TTM value through Dec 2025 reached $299.1 million, down 19.15%, while the annual FY2025 figure was $299.1 million, 19.15% down from the prior year.
  • EBT reached $84.5 million in Q4 2025 per WLKP's latest filing, down from $86.3 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $138.6 million in Q4 2021 to a low of $42.4 million in Q1 2025.
  • Average EBT over 5 years is $87.1 million, with a median of $86.1 million recorded in 2025.
  • Peak YoY movement for EBT: surged 84.13% in 2021, then crashed 52.8% in 2025.
  • A 5-year view of EBT shows it stood at $138.6 million in 2021, then plummeted by 34.02% to $91.5 million in 2022, then dropped by 4.58% to $87.3 million in 2023, then increased by 0.37% to $87.6 million in 2024, then fell by 3.58% to $84.5 million in 2025.
  • Per Business Quant, the three most recent readings for WLKP's EBT are $84.5 million (Q4 2025), $86.3 million (Q3 2025), and $86.0 million (Q2 2025).